4'-(hydroxymethyl)-3'-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)biphenyl-4-carboxylic acid

ID: ALA4210099

PubChem CID: 145967331

Max Phase: Preclinical

Molecular Formula: C28H30O3

Molecular Weight: 414.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)CCC(C)(C)c2cc(-c3cc(-c4ccc(C(=O)O)cc4)ccc3CO)ccc21

Standard InChI:  InChI=1S/C28H30O3/c1-27(2)13-14-28(3,4)25-16-21(11-12-24(25)27)23-15-20(9-10-22(23)17-29)18-5-7-19(8-6-18)26(30)31/h5-12,15-16,29H,13-14,17H2,1-4H3,(H,30,31)

Standard InChI Key:  DWYDAJOSTCLMPR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   27.2727  -24.3465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8683  -23.6408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4593  -24.3439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4555  -21.2965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8683  -22.0064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2767  -21.2940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1666  -22.4191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1666  -23.2363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5772  -22.4191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5756  -23.2345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2798  -23.6418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9861  -23.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9838  -22.4163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2790  -22.0127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6872  -22.0041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3965  -22.4121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1024  -22.0020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1002  -21.1839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3863  -20.7777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6833  -21.1903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8071  -22.4067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8080  -23.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5160  -23.6316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2236  -23.2210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2187  -22.3996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5102  -21.9967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9353  -23.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9386  -24.4448    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.6414  -23.2162    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.9731  -20.7859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9683  -19.9687    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  1  0
  6  5  1  0
  7  8  1  0
  7  5  1  0
  8  2  1  0
  2 10  1  0
  9  5  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 13 15  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 17 21  1  0
 27 28  1  0
 27 29  2  0
 24 27  1  0
 20 30  1  0
 30 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4210099

    ---

Associated Targets(Human)

RARG Tclin Retinoic acid receptor gamma (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARA Tclin Retinoic acid receptor alpha (1324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARB Tclin Retinoic acid receptor beta (1232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 414.55Molecular Weight (Monoisotopic): 414.2195AlogP: 6.56#Rotatable Bonds: 4
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.07CX Basic pKa: CX LogP: 6.78CX LogD: 3.67
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: 0.48

References

1. Thoreau E, Arlabosse JM, Bouix-Peter C, Chambon S, Chantalat L, Daver S, Dumais L, Duvert G, Feret A, Ouvry G, Pascau J, Raffin C, Rodeville N, Soulet C, Tabet S, Talano S, Portal T..  (2018)  Structure-based design of Trifarotene (CD5789), a potent and selective RARγ agonist for the treatment of acne.,  28  (10): [PMID:29706423] [10.1016/j.bmcl.2018.04.036]

Source